These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28980185)
21. Enhancement of dissolution rate of indomethacin: using liquisolid compacts. Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677 [TBL] [Abstract][Full Text] [Related]
22. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416 [TBL] [Abstract][Full Text] [Related]
23. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles. Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418 [TBL] [Abstract][Full Text] [Related]
24. Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging. Pudlas M; Kyeremateng SO; Williams LAM; Kimber JA; van Lishaut H; Kazarian SG; Woehrle GH Eur J Pharm Sci; 2015 Jan; 67():21-31. PubMed ID: 25445833 [TBL] [Abstract][Full Text] [Related]
25. [Enhancing of drug bioavailability using liquisolid system formulation]. Gajdziok J; Vraníková B Ceska Slov Farm; 2015 Jun; 64(3):55-66. PubMed ID: 26400228 [TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan. Chella N; Narra N; Rama Rao T J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826 [TBL] [Abstract][Full Text] [Related]
29. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets. Kendre PN; Chaudhari PD Drug Dev Ind Pharm; 2017 May; 43(5):751-761. PubMed ID: 27494543 [TBL] [Abstract][Full Text] [Related]
30. Aprepitant loaded solid preconcentrated microemulsion for enhanced bioavailability: A comparison with micronized Aprepitant. Kamboj S; Sharma R; Singh K; Rana V Eur J Pharm Sci; 2015 Oct; 78():90-102. PubMed ID: 26165621 [TBL] [Abstract][Full Text] [Related]
31. Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance. Sharma R; Kamboj S; Singh G; Rana V Eur J Pharm Sci; 2016 Mar; 84():55-69. PubMed ID: 26780381 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of griseofulvin release from liquisolid compacts. Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502 [TBL] [Abstract][Full Text] [Related]
33. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin. Kamble PR; Shaikh KS; Chaudhari PD Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Fahmy RH; Kassem MA Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390 [TBL] [Abstract][Full Text] [Related]
35. An Investigation into the Influence of Process Parameters and Formulation Variables on Compaction Properties of Liquisolid Systems. Aleksić I; German Ilić I; Cvijić S; Parojčić J AAPS PharmSciTech; 2020 Aug; 21(7):242. PubMed ID: 32839881 [TBL] [Abstract][Full Text] [Related]
36. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594 [TBL] [Abstract][Full Text] [Related]
37. Factors affecting performance and manufacturability of naproxen Liqui-Pellet. Lam M; Nokhodchi A Daru; 2020 Dec; 28(2):567-579. PubMed ID: 32757155 [TBL] [Abstract][Full Text] [Related]
38. Hot-melt extrusion for enhanced delivery of drug particles. Miller DA; McConville JT; Yang W; Williams RO; McGinity JW J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869 [TBL] [Abstract][Full Text] [Related]
39. Liquisolid systems to improve the dissolution of furosemide. Akinlade B; Elkordy AA; Essa EA; Elhagar S Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350 [TBL] [Abstract][Full Text] [Related]
40. Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques. Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM Drug Dev Ind Pharm; 2018 Jun; 44(6):873-885. PubMed ID: 29254384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]